The global Biosimilar Contract Manufacturing Market is experiencing unprecedented growth, projected to reach a remarkable USD 51.9 billion by 2035. This expansion is spurred by a compound annual growth rate (CAGR) of 18.9% from now until then. Increasing healthcare costs have prompted a surge in demand for biosimilars, particularly as patent expirations of major biologics pave the way for more...